Calcium-regulating hormones vitamin D and parathyroid hormone

Endocrinology: Basic and Clinical Principles: Second Edition

Volumn , Issue , 2005, Pages 283-299

  Hendy, Geoffrey N ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891387784     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-829-8_18     Document Type: Chapter

References (18)

1. Clemens TL, Adams JS. Vitamin D and metabolites. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 3rd Ed. New York, NY: Raven 1996:109-114.
2. Goltzman D, Hendy GN. Parathyroid hormone. In: Becker KL, ed. Principles and Practice of Endocrinology and Metabolism, 3rd Ed. Philadelphia, PA: JB Lippincott, 2001:497-512.
3. Haussler MR, Jurutka PW, Hsieh J-C, Thompson PD, Selznick SH, Haussler Ca, Whitfield GK. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone 1995;17(Suppl):33S-38S.
4. John MR, Arai M, Rubin DA, Jonsson KB, Juppner H. Identification and characterization of the murine and human gene encoding the tuberoinfundibular peptide of 39 residues. Endocrinology 2002;143:1047-1057.
5. Levine MA, Schwindinger WF, Downs RW Jr, Moses AM. Pseudohypoparathyroidism: clinical, biochemical, and molecular features. In: Bilezikian JP, Marcus R, Levine MA, eds. The Parathyroids. Basic and Clinical Concepts. New York, NY: Raven 1994:781-800.
6. Minghetti PP, Norman AW. 1, 25 (OH) 2-Vitamin D3 receptors: gene regulation and genetic circuitry. FASEB J 1988;2:3043-3053.
7. Yu J, Papavasiliou V, Rhim J, Goltzman D, Kremer R. Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia. Anti-Cancer Drugs 1995;6:101-108.
8. Bilezikian JP, Marcus R, Levine MA, eds. The Parathyroids: Basic and Clinical Concepts. New York, NY: Raven 2001.
9. Brown EM, Macleod J. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001;81:239-297.
10. Christakos S, Dhawan P, Liu Y, Peng X, Porta A. New insights into the mechanisms of vitamin D action. J Cell Biochem 2003;88:695-705.
11. Cole D E C, Hendy GN. Hypoparathyroidism and pseudohypoparathyroidism. In: Arnold A, ed. Endotext.com. Bone/Mineral Metabolism section. Website: www.endotext.org/index.htm, 2002.
12. Favus MF, ed. Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th Ed. New York, NY: Raven 2003.
13. Hendy GN, Arnold A. Molecular basis of PTH overexpression. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. San Diego, CA: Academic 2002:1017-1030.
14. Hendy GN, Cole D E C. Parathyroid disorders. In: Emery AEH, Rimoin DL, eds. Principles and Practice of Medical Genetics, 4th Ed., vol. 2. Edinburgh: Churchill Livingstone2002:2203-2230.
15. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004;79:362-371.
16. Juppner H, Potts JT Jr. Immunoassays for the detection of parathyroid hormone. J Bone Miner Res 2002;17(Suppl 1):N81-N86.
17. Karaplis AC, Goltzman D. PTH and PTHrP effects on the skeleton. Rev Endocr Metab Disord 2000;1:331-341.
18. Sutton A L M, MacDonald PN. Vitamin D: more than a "bone-a- fide" hormone. Mol Endocrinol 2003;17:777-791.